Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.

about

Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.

P2860

Q47554082-1E49218B-9A5E-46C9-940F-FC62C2883D6B

P2860

Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.

Item

http://www.wikidata.org/entity/Q40494843

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Successful treatment of three ...... daclatasvir plus asunaprevir.

@en

type

Item

label

Successful treatment of three ...... daclatasvir plus asunaprevir.

@en

prefLabel

Successful treatment of three ...... daclatasvir plus asunaprevir.

@en

P1476

Successful treatment of three ...... daclatasvir plus asunaprevir.

@en

P2093

Chiaki Okuse

http://www.w3.org/2001/XMLSchema#string

Fumio Itoh

http://www.w3.org/2001/XMLSchema#string

Hiroaki Iwase

http://www.w3.org/2001/XMLSchema#string

Hiroki Ikeda

http://www.w3.org/2001/XMLSchema#string

Junji Imamura

http://www.w3.org/2001/XMLSchema#string

Masaaki Shimada

http://www.w3.org/2001/XMLSchema#string

Noboru Hirashima

http://www.w3.org/2001/XMLSchema#string

Nobumitsu Ryuge

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Matsumoto

http://www.w3.org/2001/XMLSchema#string

Tsunamasa Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre

P2888

s12328-016-0693-0

P304

41-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-016-0693-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27766544

http://www.w3.org/2001/XMLSchema#string

Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.

about

P2860

P2860

Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698